Chemical Compound

Gadolinium, (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N(sup 1),N(sup 4),N(sup 7),N(sup 10),O(sup 1),O(sup 4),O(sup 7),O(sup 10))-

CAS Registry Number 120066-54-8
Gadolinium, (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N(sup 1),N(sup 4),N(sup 7),N(sup 10),O(sup 1),O(sup 4),O(sup 7),O(sup 10))- 结构式
Primary record

Gadolinium, (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N(sup 1),N(sup 4),N(sup 7),N(sup 10),O(sup 1),O(sup 4),O(sup 7),O(sup 10))-

库存
2,914 克
纯度
99.6 %
CAS
120066-54-8

化合物标识与属性

CAS
120066-54-8
PubChem CID
60714
SMILES
CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]
Canonical SMILES
CC(O)CN1CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC1.[Gd+3]

名称与同义词

  • GADOTERIDOL
  • ProHance
  • Gadoteridolum
  • Prohance Multipack
  • Gadolinium-HP-DO3A
  • Prohance (TN)
  • 120066-54-8
  • Gadolinium-HP-Do 3A
  • GD-HP-DO 3A
  • Gd-HPDO3A
  • gadolinium HP-DO3A
  • GdHPDO3A
  • Gd-HP-DO3A
  • Gadolinium-HP-D03A
  • H-D-Ile-Asp-OH
  • Gd-hydroxypropyl-D03A
  • RefChem:56478
  • GADOTERIDOL [MI]
  • GADOTERIDOL [INN]
  • GADOTERIDOL [JAN]
  • Gd(DO3A)
  • Gd(HP-DO3A)
  • C17H29GdN4O7
  • DTXSID2048662
  • GADOTERIDOL [HSDB]
  • GADOTERIDOL [USAN]
  • D0M1PL
  • Gd-HP-D03A
  • GADOTERIDOL [VANDF]
  • Gadoteridolum [INN-Latin]
  • AC1L1TS2
  • GADOTERIDOL [MART.]
  • DTXCID5028588
  • GADOTERIDOL [USP-RS]
  • GADOTERIDOL [WHO-DD]
  • HSDB 7549
  • Gadoteridol (JAN/USP/INN)
  • DPNNNPAKRZOSMO-UHFFFAOYSA-K
  • SCHEMBL1650466
  • SQ-32692
  • UNII-0199MV609F
  • CHEBI:31643
  • GADOTERIDOL [ORANGE BOOK]
  • V08CA04
  • GADOTERIDOL [USP IMPURITY]
  • HMS3264D11
  • HMS5087L05
  • MOLI001032
  • 0199MV609F
  • C17-H29-Gd-N4-O7
  • GADOTERIDOL [USP MONOGRAPH]
  • NSC-760055
  • BCP13402
  • CID60714
  • Gadoteridol [USAN:BAN:INN:JAN]
  • Gadoteridol [USAN:INN:BAN:JAN]
  • Tox21_113025
  • Tox21_113128
  • EBC-27320
  • SQ 32692
  • Tox21_113025_1
  • ACN-043393
  • CCG-213206
  • DB00597
  • SQ 32,692
  • Gadoteridol [USAN:USP:INN:BAN:JAN]
  • NCGC00182068-02
  • NCGC00182068-03
  • NCGC00182068-04
  • BC678010
  • CAS-120066-54-8
  • E0006
  • NS00078663
  • D01137
  • F85197
  • A996213
  • Q5516429
  • 2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
  • (+-)-(10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))gadolinium
  • (10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato)gadolinium
  • Gadolinium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane
  • gadolinium 2,2',2''-[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate
  • gadolinium 1,4,7-tris(carboxymethyl)-10-(2'-hydroxypropyl)-1,4,7,10-tetraazacyclododecane
  • (+/-)-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATO(3-))GADOLINIUM.
  • [10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7,O10]gadolinium
  • 1,4,7,10-Tetraazacyclododecan-1,4,7-triacetic acid, 10-(2-hydroxypropyl)-, gadolinium complex
  • 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid gadolinium complex
  • 112188-16-6
  • 120067-35-8
  • gadolinium 2,2',2''-(10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
  • gadolinium(3+) 2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate
  • gadolinium(3+) ion 2-(4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetate
  • gadolinium(3+); 2-[4-(2-hydroxypropyl)-7,10-bis(2-oxido-2-oxoethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate
  • gadolinium(III) 2,2',2''-(10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
  • Gadolinium, (1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7)-
  • Gadolinium, (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N(sup 1),N(sup 4),N(sup 7),N(sup 10),O(sup 1),O(sup 4),O(sup 7),O(sup 10))-
  • GADOLINIUM, (10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATO(3-)-N1,N4,N7,N10,O1,O4,O7,O10)-
  • SQ-32692; SQ 32692; SQ32692; Gd-HP-DO3A; GD-HP-DO 3A;Gd-HPDO3A;Gd-hydroxypropyl-D03A